Abbott Seeks Expanded Labeling For CardioMEMS HF Monitor Based On GUIDE HF Results
The GUIDE HF investigators contend the trial missed its primary endpoint because of COVID-19.

The GUIDE HF investigators contend the trial missed its primary endpoint because of COVID-19.